How nanoparticle vaccine fights many flu strains

March 24, 2021

How nanoparticle vaccine fights many flu strains

We have annual flu vaccines because the influenza virus mutates every year.  The antibodies you made for this season's flu  many not protect you against next year's flu version  That's why many scientists are trying to create a universal flu vaccine that could provide protection against a broad range of flu virus strains.

Neil King, assistant professor of biochemistry and a researcher at the UW Medicine Institute for Protein Design, explains the latest success on the road to a universal flu vaccine. A paper today in Nature describes work by his team and the NIH Vaccine Research Center on a nanoparticle flu vaccine that, in animal trials, provided broad immunity against multiple flu strains, both season and pandemic.  He tells how the experimental vaccine was created.

Next steps will be clinical trials, now in the planning stages. 

Read our news release about the paper published March 24 in the journal Nature.

Access downloadable video resources of Neil King.  

Institute for Protein Design

Terms of appropriate usage of file downloads

  • News reporters and news organizations may freely republish and distribute videos, still images and audio files produced by UW Medicine and the University of Washington School of Medicine.
  • Works must be attributed/credited appropriately (for example, “UW Medicine” – as denoted in the file) and must not be used for commercial purposes.
  • These visual and audio files may not be used to exploit or misrepresent UW Medicine or the University of Washington.
  • UW Medicine often licenses still images and stock video from Getty Images, but we cannot grant republishing rights. You may not republish single image files, videos or animations credited to Getty Images.
  • Logos of UW Medicine and University of Washington Health Sciences schools may not be republished without explicit permission. Contact us by phone or email: 206.543.3620 or